UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
American Journal of Physiology: Cell Physiology, ISSN 0363-6143, 2017, Volume 313, Issue 1, pp. C3 - C10
Plasma | Neurofilament | Alzheimer’s disease | Neurogranin | Biomarkers | Serum | Tau | Amyloid | Cerebrospinal fluid | Blood | Diagnosis, Differential | Peptide Fragments - cerebrospinal fluid | Humans | Neurodegenerative Diseases - diagnosis | Fatty Acid-Binding Proteins - cerebrospinal fluid | Neurodegenerative Diseases - blood | tau Proteins - cerebrospinal fluid | Biomarkers - blood | Alzheimer Disease - cerebrospinal fluid | Intermediate Filaments - metabolism | Neurodegenerative Diseases - cerebrospinal fluid | Alzheimer Disease - diagnosis | Amyloid beta-Peptides - cerebrospinal fluid | Neurocalcin - cerebrospinal fluid | Neurogranin - cerebrospinal fluid | Biomarkers - cerebrospinal fluid | Alzheimer Disease - blood | Occludin - blood | Physiological aspects | Body fluids | Biological markers | Alzheimer's disease | Temporal lobe | Neurodegenerative diseases | Parenchyma | Lewy bodies | Studies | Pathology | Fluids | Senile plaques | Tau protein | Neurodegeneration | Alzheimers disease | Plaques | Index Medicus | amyloid | neurofilament | biomarkers | cerebrospinal fluid | Theme | tau | plasma | serum | blood | neurogranin | amyloid beta protein | Data- och informationsvetenskap | Neurosciences | Fatty Acid-Binding Proteins | Peptide Fragments | Alzheimer disease | fatty acid binding protein | neurocalcin | tau Proteins | Intermediate Filaments | VSNL1 protein | Amyloid beta-Peptides | MAPT protein | peptide fragment | NRGN protein | Diagnosis | human | Neurovetenskaper | Neurodegenerative Diseases | differential diagnosis | amyloid beta-protein (1-42) | Differential | occludin | intermediate filament | biological marker | Computer and Information Science | OCLN protein | metabolism | tau protein | Neurodegenerative Diseases/blood/cerebrospinal fluid/diagnosis | Biomarkers/blood/cerebrospinal fluid | tau Proteins/cerebrospinal fluid | Neurogranin/cerebrospinal fluid | Occludin/blood | Neurocalcin/cerebrospinal fluid | Neurologi | Peptide Fragments/cerebrospinal fluid | Amyloid beta-Peptides/cerebrospinal fluid | Fatty Acid-Binding Proteins/cerebrospinal fluid | Neurology | Intermediate Filaments/metabolism | Alzheimer Disease/blood/cerebrospinal fluid/diagnosis
Journal Article
JAMA neurology, ISSN 2168-6149, 03/2019, Volume 76, Issue 3, pp. 318 - 325
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Frontotemporal Dementia - cerebrospinal fluid | Parkinsonian Disorders - cerebrospinal fluid | Humans | Middle Aged | Parkinsonian Disorders - diagnosis | Dementia - diagnosis | Male | Intermediate Filaments - metabolism | Case-Control Studies | Alzheimer Disease - diagnosis | Neurofilament Proteins - cerebrospinal fluid | Parkinson Disease - cerebrospinal fluid | Aged, 80 and over | Amyloid beta-Peptides - cerebrospinal fluid | Cognition - physiology | Dementia - cerebrospinal fluid | Female | Cognitive Dysfunction - diagnosis | tau Proteins - cerebrospinal fluid | Cognitive Dysfunction - cerebrospinal fluid | Motor Neuron Disease - cerebrospinal fluid | Alzheimer Disease - cerebrospinal fluid | Frontotemporal Dementia - diagnosis | Parkinson Disease - diagnosis | Aged | Biomarkers - cerebrospinal fluid | Motor Neuron Disease - diagnosis | Brain | Parkinson's disease | Cognitive ability | Disorders | Impairment | Cognition | Cerebrospinal fluid | Proteins | Motor neuron diseases | Autopsy | Neurodegeneration | Dementia disorders | Degeneration | Paralysis | Light levels | Alzheimer's disease | Movement disorders | Autopsies | Neurodegenerative diseases | Motor neurone disease | Amyotrophic lateral sclerosis | Disease control | Lewy bodies | Diseases | Neurological diseases | Cognition & reasoning | Tau protein | Progressive supranuclear palsy | Correlation analysis | β-Amyloid | Frontotemporal dementia | Dementia
Journal Article
JAMA neurology, ISSN 2168-6149, 2019, Volume 76, Issue 9, pp. 1035 - 1048
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Immunoassay | Multiple sclerosis | Sexually transmitted diseases--STD | Parkinson's disease | Central nervous system | Parkinsons disease | Disorders | Sex | Systematic review | Cerebrospinal fluid | Inflammatory diseases | Proteins | Human immunodeficiency virus--HIV | Dementia disorders | Diagnosis | Alzheimer's disease | Age | Movement disorders | Level (quantity) | Neurodegenerative diseases | Amyotrophic lateral sclerosis | Reporting | Age factors | Neurological diseases | Neurology | Men | Biomarkers | Diagnostic systems | Frontotemporal dementia | Dementia
Journal Article
Lancet neurology, ISSN 1474-4422, 2011, Volume 10, Issue 3, pp. 230 - 240
Neurology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Cross-Sectional Studies | Lewy Body Disease - diagnosis | Humans | Middle Aged | Male | tau Proteins - cerebrospinal fluid | Alzheimer Disease - cerebrospinal fluid | Alzheimer Disease - diagnosis | Multiple System Atrophy - cerebrospinal fluid | alpha-Synuclein - cerebrospinal fluid | Parkinson Disease - cerebrospinal fluid | Aged, 80 and over | Parkinson Disease - diagnosis | Adult | Female | Lewy Body Disease - cerebrospinal fluid | Aged | Biomarkers - cerebrospinal fluid | Multiple System Atrophy - diagnosis | Cohort Studies | Index Medicus | Brain | Basal ganglia | Deposits | Parkinson's disease | Hydrocephalus | Neurodegenerative diseases | biomarkers | Central nervous system diseases | Clinical trials | Cerebrospinal fluid | Synuclein | Statistics | Lewy bodies | Atrophy | Neurological diseases | Hospitals | Tau protein | Dementia disorders | Alzheimer's disease | Age | Enzyme-linked immunosorbent assay | Movement disorders | progressive supranuclear palsy
Journal Article
Movement disorders, ISSN 0885-3185, 09/2019, Volume 34, Issue 9, pp. 1354 - 1364
cohort studies | outcome research | Parkinson's disease/parkinsonism | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neuroimaging | Metabolomics | Parkinson's disease | Dopamine | Neurodegenerative diseases | Secretion | Parkinsons disease | Cognitive ability | Sleep (REM) | Cerebrospinal fluid | Synuclein | Sleep disorders | Neurodegeneration | Proteomics | Hemoglobin | Biomarkers | Dopamine transporter | Age | Movement disorders | Dopamine receptors | Index Medicus | parkinsonism | Parkinson’s disease
Journal Article
Biochemical and biophysical research communications, ISSN 0006-291X, 2006, Volume 349, Issue 1, pp. 162 - 166
α-Synuclein | Biomarker | Neurodegenerative diseases | Parkinson disease | Cerebrospinal fluid | Diagnosis | ELISA | Biochemistry & Molecular Biology | Biophysics | Life Sciences & Biomedicine | Science & Technology | Humans | Middle Aged | Gene Expression Regulation | Male | Case-Control Studies | alpha-Synuclein - cerebrospinal fluid | Parkinson Disease - cerebrospinal fluid | Adolescent | Sex Factors | Aged, 80 and over | Aging | Parkinson Disease - diagnosis | Adult | Female | Aged | Index Medicus
Journal Article
Annals of neurology, ISSN 0364-5134, 04/2009, Volume 65, Issue 4, pp. 403 - 413
Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neurology | Biological and medical sciences | Medical sciences | Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases | Phosphorylation | Apolipoprotein E4 - genetics | Area Under Curve | Humans | Middle Aged | Male | Threonine - metabolism | tau Proteins - chemistry | Alzheimer Disease - pathology | Sensitivity and Specificity | Statistics, Nonparametric | Aged, 80 and over | Amyloid beta-Peptides - cerebrospinal fluid | Female | Retrospective Studies | Cognition Disorders - cerebrospinal fluid | Peptide Fragments - cerebrospinal fluid | Cognition Disorders - pathology | Cognition Disorders - genetics | tau Proteins - cerebrospinal fluid | Alzheimer Disease - cerebrospinal fluid | Disease Progression | Diagnostic Imaging | ROC Curve | Aged | Biomarkers - cerebrospinal fluid | Alzheimer Disease - genetics | Cohort Studies | Neuroimaging | Neurodegenerative diseases | Threonine | biomarkers | Cognitive ability | Data processing | Cerebrospinal fluid | Regression analysis | Tau protein | Autopsy | Alzheimer's disease | Immunoassays | Geriatrics | Index Medicus | Peptide Fragments | pathology | Biological Markers | MEDICIN OCH HÄLSOVETENSKAP | tau Proteins | 80 and over | genetics | MEDICAL AND HEALTH SCIENCES | chemistry | Apolipoprotein E4 | Alzheimer Disease | Statistics | Amyloid beta-Protein | Nonparametric | Cognition Disorders | cerebrospinal fluid | metabolism
Journal Article
Movement disorders, ISSN 0885-3185, 10/2017, Volume 32, Issue 10, pp. 1423 - 1431
Parkinson's disease | β‐glucocerebrosidase | GBA1 gene | CSF biomarkers | lysosomal enzyme activity | β-glucocerebrosidase | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Glucosylceramidase - genetics | Peptide Fragments - cerebrospinal fluid | Humans | Middle Aged | Male | Statistics as Topic | tau Proteins - cerebrospinal fluid | Parkinson Disease - genetics | Glucosylceramidase - cerebrospinal fluid | Mutation - genetics | beta-N-Acetylhexosaminidases - cerebrospinal fluid | Lysosomes - metabolism | alpha-Synuclein - cerebrospinal fluid | Parkinson Disease - cerebrospinal fluid | Amyloid beta-Peptides - cerebrospinal fluid | Female | ROC Curve | Aged | Cathepsin D - cerebrospinal fluid | Enzymes | Neurodegenerative diseases | Lysosomal enzymes | Cognitive ability | Parkinsons disease | Cathepsin D | Glucosylceramidase | Cerebrospinal fluid | Mutation | Movement disorders | Index Medicus
Journal Article
Movement disorders, ISSN 0885-3185, 11/2018, Volume 33, Issue 11, pp. 1724 - 1733
dementia with Lewy bodies | Neuroscience(all) | biomarkers | α-synuclein | CSF | α‐synuclein | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Parkinson Disease - diagnostic imaging | Peptide Fragments - cerebrospinal fluid | Humans | Middle Aged | Tomography, Emission-Computed, Single-Photon | Male |